Luca Moscetti

8PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 30, 2026
Challenging the cornerstone: Toward risk-adapted follow-up in early breast cancer.

|Apr 08, 2026
Ten tips to reduce gaps in daily oncology practice.

Luca Moscetti, Antonella Ferro, Catia Angiolini

|Jul 01, 2025
Impact of Ethnicity on Breast Cancer Outcome: A Systematic Review and Meta-Analysis of Randomized Phase III Trials of the Last Decade.

Emma Zattarin, Luca Moscetti, Elisa D'Agostino

|Jan 27, 2025
Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments.

Lorenzo Belluzzi, Giulio Martinelli, Bianca Medici

|Jul 05, 2022
Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab.

Francesca Ligorio, Serena Di Cosimo, Paolo Verderio

|Dec 23, 2020
Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2- Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series.

Armando Orlandi, Elena Iattoni, Laura Pizzuti

Pageof 2

Frequent Collaborators

2 joint publications

Claudia Omarini

2 joint publications

Federico Piacentini

2 joint publications

Catia Angiolini

1 joint publications

Sara Balduzzi